Filter by: Subject

Filter by: Subject

Results Per Page:

Artificial intelligence (AI) (3)
Cell cycle (3)
Cervical cancer (3)
Colorectal cancer (CRC) (3)
Coronavirus disease 2019 (COVID-19) (3)
COVID-19 pandemic (3)
Lopinavir/ritonavir (LPV/r) (3)
Metabolites (3)
Metastasis (3)
Next-generation sequencing (NGS) (3)
Non-AIDS defining cancers (NADCs) (3)
Obesity (3)
Prognosis (3)
Ribonucleic acid (RNA) (3)
SDG-09: Industry, innovation and infrastructure (3)
Aberrant splicing (2)
Acquired immune deficiency syndrome (AIDS) (2)
Adenocarcinoma (2)
Africa (2)
Antiretroviral therapy (ART) (2)
Bioinformatics (2)
Biomarker (2)
Brazil (2)
Carcinogenesis (2)
Cell cycle regulation (2)
Cervical cancer (CC) (2)
Competing endogenous RNAs (ceRNAs) (2)
Differential gene expression (2)
DNA damage response (DDR) (2)
Domain with no name (DWNN) (2)
Editorial (2)
Efavirenz (EFV) (2)
Endometrial cancer (2)
Epigenetic modifications (2)
Gastric cancer (2)
Green nanotechnology (2)
Head and neck squamous cell carcinoma (HNSCC) (2)
Highly active antiretroviral therapy (HAART) (2)
Immunosuppression (2)
India (2)
Ingenuity pathway analysis (IPA) (2)
Long non-coding RNAs (lncRNAs) (2)
Machine learning (2)
Microbiome (2)
Microbiota (2)
MicroRNA (miRNA) (2)
MicroRNAs (miRNAs) (2)
Multi-omics (2)
Neurogenesis (2)
Oesophageal cancer (2)
p53 (2)
Papillary thyroid carcinoma (PTC) (2)
Patients (2)
Personalized medicine (2)
Phytomedicine (2)
Prostate cancer (PCa) (2)
Retinoblastoma binding protein 6 (RBBP6) (2)
SDG-10: Reduced inequalities (2)
South Africa (2)
Splice variants (2)
SR proteins (2)
Tanzania (2)
Tumor microenvironment (TME) (2)
Venous thromboembolism (VTE) (2)
2,2 Diphenyl-1-picryl hydrazyl (DPPH) (1)
A549 cells (1)
Aberrant splicing events (1)
Absorption, distribution, metabolism, and excretion (ADME) (1)
Acute myeloid leukaemia (AML) (1)
Acute myeloid leukemia (AML) (1)
Adhesion (1)
Adipose tissue (1)
Adoptive cell therapy (ACT) (1)
Adrenomedullin (1)
African norms (1)
African population (1)
AIDS defining cancers (ADCs) (1)
AIDS-defining cancers (ADCs) (1)
AIDS-KS patients (1)
Alcohol consumption (1)
Alpha-pinene (1)
Alternate splicing (1)
Alternative mRNA splicing (AS) (1)
Alternative splicing (AS) (1)
Alzheimer’s disease (1)
Amyloid-beta (1)
Anastrozole (1)
Androgen receptor (AR) (1)
Anemia (1)
Angiotensin-aldosterone system (1)
Anti-cancer (1)
Anticancer (1)
Anticancer activity (1)
Anticoagulation practice (1)
Anticoagulation therapy (1)
Antimicrobial (1)
Antioxidant (1)
Antiretroviral (ARV) (1)
Apoptosis (1)
Arterial thrombosis (1)